Three case studies illustrate the utility of advanced implantable hemodynamic monitors (IHMs). The cases include a 70-year-old with ischemic cardiomyopathy, chronic kidney disease, and recurrent volume overload; a 53-year-old with ischemic heart disease, mild effort-related angina, and New York Heart Association class III chronic heart failure; and a 21-year-old with severe dilated cardiomyopathy, all 3 patients having an IHM. The outcomes in these cases illustrate the capability of the IHM system for monitoring and detecting early changes in hemodynamic data and the use of these data to adjust medical therapies and reduce morbidity and risk of hospitalization. When pathologic hemodynamic changes are observed, this alerts the cardiologist to search for underlying causes, even when a patient on initial questioning denies any change in compliance or symptoms. © 2006 MedReviews, LLC.